Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Wesana Health Holdings Inc. (C:WESA)

Business Focus: Biotechnology & Medical Research

Sector:  Healthcare Industry:  Biotechnology & Medical Research
See Regulatory Filings on SEDAR
Company Contact
Address: 82 Richmond Street East
The Canadian Venture Building
Tel: N/A
Website: N/A
Key People
Business Overview
Wesana Health Holdings Inc, formerly Debut Diamonds Inc. (Debut), is a Canada-based life science company. The Company is engaged in development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain injury (TBI) and related conditions. It develops evidence-based formulations and protocols for patients to overcome neurological, psychological and mental health ailments caused by trauma.
Financial Overview
For the nine months ended 31 January 2021, WesanaHealth Holdings Inc revenues was not reported. Net lossdecreased 39% to C$72K. Lower net loss reflectsProfessional Fees(1) decrease of 39% to C$50K (expense),Insurance decrease from C$11K (expense) to C$0K, Traveldecrease from C$6K (expense) to C$0K. Basic Earnings perShare excluding Extraordinary Items increased from -C$0.11to -C$0.08.
Reporting Currency: Canadian Dollars
Enterprise value: $36.09M as of Jan 31, 2021
Annual revenue (TTM): $0.00M as of Jan 31, 2021
EBITDA (TTM): -$0.10M as of Jan 31, 2021
Net annual income (TTM): -$0.10M as of Jan 31, 2021
Free cash flow (TTM): -$0.06M as of Jan 31, 2021
Net Debt Last Fiscal Year: N/A
Shares outstanding: 12,578,997 as of May 10, 2021
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization